VID-KIDS Intervention Program for Depression, Postpartum

Phase-Based Progress Estimates
Depression, Postpartum+2 More
VID-KIDS Intervention Program - Behavioral
Any Age
What conditions do you have?

Study Summary

This trial is testing whether a nurse-guided video feedback intervention can improve mother-infant interactions in the context of postpartum depression, and in turn, improve infant cortisol patterns and development.

Eligible Conditions
  • Depression, Postpartum
  • Postpartum Depression

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 18 weeks

Week 18
NCAST assessment scale will be used to evaluate Mother-Infant (M-I) interactions

Trial Safety

Trial Design

2 Treatment Groups

Control Group
1 of 2
VID-KIDS Intervention Program Group
1 of 2

Active Control

Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: VID-KIDS Intervention Program · No Placebo Group · N/A

VID-KIDS Intervention Program Group
Experimental Group · 1 Intervention: VID-KIDS Intervention Program · Intervention Types: Behavioral
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 18 weeks

Who is running the clinical trial?

University of CalgaryLead Sponsor
701 Previous Clinical Trials
491,926 Total Patients Enrolled
2 Trials studying Depression, Postpartum
130 Patients Enrolled for Depression, Postpartum
Alberta Health servicesOTHER
143 Previous Clinical Trials
309,162 Total Patients Enrolled
1 Trials studying Depression, Postpartum
100 Patients Enrolled for Depression, Postpartum
Nicole L Letourneau, RN, PhDPrincipal InvestigatorUniversity of Calgary

Eligibility Criteria

Age Any Age · Female Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 3rd, 2021

Last Reviewed: November 27th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.